vimarsana.com
Home
Live Updates
LEO Pharma presents new Adtralza® (tralokinumab) data f
LEO Pharma presents new Adtralza® (tralokinumab) data f
LEO Pharma presents new Adtralza® (tralokinumab) data following long-term continuous treatment at EADV 30th Congress
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related Keywords
Japan ,
Portland ,
Oregon ,
United States ,
Denmark ,
United Kingdom ,
Ballerup ,
Hovedstaden ,
Japanese ,
Great Britain ,
Henrik Heskjaer ,
Linda Mayer ,
Andrew Blauvelt ,
Oregon Medical Research Center ,
Global Research ,
European Academy Of Dermatology ,
Regulatory Agency In Great Britain ,
European Commission ,
Global External Communications ,
Global Product Communications ,
European Academy ,
Eczema Area ,
Severity Index ,
Numeric Rating Scale ,
Executive Vice President ,
Regulatory Agency ,
Term Extension ,
Business Wire ,
Coronavirus Pandemic ,
Business ,
Lifestyle ,
Medical Research ,
Europe ,
Health ,